Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.

Davis MT, Hillmer A, Holmes SE, Pietrzak RH, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Carson RE, Krystal JH, Esterlis I.

Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11490-11495. doi: 10.1073/pnas.1818871116. Epub 2019 May 13. Erratum in: Proc Natl Acad Sci U S A. 2019 Jun 17;:.

PMID:
31085640
2.

Severe Illness Anxiety Treated by Integrating Inpatient Psychotherapy With Medical Care and Minimizing Reassurance.

Higgins-Chen AT, Abdallah SB, Dwyer JB, Kaye AP, Angarita GA, Bloch MH.

Front Psychiatry. 2019 Mar 22;10:150. doi: 10.3389/fpsyt.2019.00150. eCollection 2019.

3.

Lower synaptic density is associated with depression severity and network alterations.

Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, Sanacora G, Krystal JH, Carson RE, Esterlis I.

Nat Commun. 2019 Apr 4;10(1):1529. doi: 10.1038/s41467-019-09562-7.

4.

Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III.

Moore KE, Oberleitner LMS, Zonana HV, Buchanan AW, Pittman BP, Verplaetse TL, Angarita GA, Roberts W, McKee SA.

J Clin Psychiatry. 2019 Feb 12;80(2). pii: 18m12317. doi: 10.4088/JCP.18m12317.

PMID:
30758921
5.

Neuroactive steroid levels and cocaine use chronicity in men and women with cocaine use disorder receiving progesterone or placebo.

Milivojevic V, Covault J, Angarita GA, Siedlarz K, Sinha R.

Am J Addict. 2019 Jan;28(1):16-21. doi: 10.1111/ajad.12828. Epub 2018 Dec 11.

6.

Hypothalamic response to cocaine cues and cocaine addiction severity.

Zhang S, Zhornitsky S, Angarita GA, Li CR.

Addict Biol. 2018 Oct 8. doi: 10.1111/adb.12682. [Epub ahead of print]

PMID:
30295396
7.

Peripheral immune system suppression in early abstinent alcohol-dependent individuals: Links to stress and cue-related craving.

Fox HC, Milivojevic V, Angarita GA, Stowe R, Sinha R.

J Psychopharmacol. 2017 Jul;31(7):883-892. doi: 10.1177/0269881117691455. Epub 2017 Feb 21.

8.

In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependence.

Hillmer AT, Sandiego CM, Hannestad J, Angarita GA, Kumar A, McGovern EM, Huang Y, O'Connor KC, Carson RE, O'Malley SS, Cosgrove KP.

Mol Psychiatry. 2017 Dec;22(12):1759-1766. doi: 10.1038/mp.2017.10. Epub 2017 Feb 28.

9.

Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder.

Worhunsky PD, Matuskey D, Gallezot JD, Gaiser EC, Nabulsi N, Angarita GA, Calhoun VD, Malison RT, Potenza MN, Carson RE.

Neuroimage. 2017 Mar 1;148:343-351. doi: 10.1016/j.neuroimage.2017.01.045. Epub 2017 Jan 19.

10.

Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO.

Gaiser EC, Gallezot JD, Worhunsky PD, Jastreboff AM, Pittman B, Kantrovitz L, Angarita GA, Cosgrove KP, Potenza MN, Malison RT, Carson RE, Matuskey D.

Neuropsychopharmacology. 2016 Dec;41(13):3042-3050. doi: 10.1038/npp.2016.115. Epub 2016 Jul 4.

11.

Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.

Angarita GA, Emadi N, Hodges S, Morgan PT.

Addict Sci Clin Pract. 2016 Apr 26;11(1):9. doi: 10.1186/s13722-016-0056-7. Review.

12.

Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence.

Morgan PT, Angarita GA, Canavan S, Pittman B, Oberleitner L, Malison RT, Mohsenin V, Hodges S, Easton C, McKee S, Bessette A, Forselius E.

Drug Alcohol Depend. 2016 Mar 1;160:49-56. doi: 10.1016/j.drugalcdep.2015.12.004. Epub 2016 Jan 8.

13.

A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.

Matuskey D, Gaiser EC, Gallezot JD, Angarita GA, Pittman B, Nabulsi N, Ropchan J, MaCleod P, Cosgrove KP, Ding YS, Potenza MN, Carson RE, Malison RT.

Drug Alcohol Depend. 2015 Sep 1;154:167-73. doi: 10.1016/j.drugalcdep.2015.06.039. Epub 2015 Jun 30.

14.

Correlates of polysomnographic sleep changes in cocaine dependence: self-administration and clinical outcomes.

Angarita GA, Canavan SV, Forselius E, Bessette A, Morgan PT.

Drug Alcohol Depend. 2014 Oct 1;143:173-80. doi: 10.1016/j.drugalcdep.2014.07.025. Epub 2014 Jul 30.

15.

Abstinence-related changes in sleep during treatment for cocaine dependence.

Angarita GA, Canavan SV, Forselius E, Bessette A, Pittman B, Morgan PT.

Drug Alcohol Depend. 2014 Jan 1;134:343-347. doi: 10.1016/j.drugalcdep.2013.11.007. Epub 2013 Nov 17.

16.

Regulation of cocaine self-administration in humans: lack of evidence for loading and maintenance phases.

Angarita GA, Pittman B, Gueorguieva R, Kalayasiri R, Lynch WJ, Sughondhabirom A, Morgan PT, Malison RT.

Pharmacol Biochem Behav. 2010 Mar;95(1):51-5. doi: 10.1016/j.pbb.2009.12.005. Epub 2009 Dec 21.

17.

A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men.

Loebl T, Angarita GA, Pachas GN, Huang KL, Lee SH, Nino J, Logvinenko T, Culhane MA, Evins AE.

J Clin Psychiatry. 2008 Mar;69(3):480-6.

PMID:
18294021
18.

No-Show for Treatment in Substance Abuse Patients with Comorbid Symptomatology: Validity Results from a Controlled Trial of the ASAM Patient Placement Criteria.

Angarita GA, Reif S, Pirard S, Lee S, Sharon E, Gastfriend DR.

J Addict Med. 2007 Jun;1(2):79-87. doi: 10.1097/ADM.0b013e3180634c1d.

PMID:
21768939
19.

Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes.

Pirard S, Sharon E, Kang SK, Angarita GA, Gastfriend DR.

Drug Alcohol Depend. 2005 Apr 4;78(1):57-64. Epub 2004 Nov 21.

PMID:
15769558

Supplemental Content

Loading ...
Support Center